SLNO — Soleno Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual balance sheet for Soleno Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21.3	14.6	170	291	305
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	28.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	22.4	15.6	171	294	356
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.454	0.157	0.419	2.98	2.38
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	35.6	26.5	181	331	564
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.01	7.31	11.5	18.7	61.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.8	16.1	23.2	85.9	114
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	17.8	10.3	158	245	450
Total Liabilities & Shareholders' Equity	35.6	26.5	181	331	564
Total Common Shares Outstanding